UPHARM LIMITED
Registered number: | 13875631
Balance Sheet
as at 31 January 2025
Notes |  |  | 2025 |  |  | 2024
£ | £
Current assets
Cash at bank and in hand |  |  | 106 |  |  | 206
Creditors: amounts falling due within one year | 3 |  | (585) |  |  | -
Net current (liabilities)/assets |  |  |  | (479) |  |  | 206
Total assets less current liabilities |  |  |  | (479) |  |  | 206
Creditors: amounts falling due after more than one year | 4 |  |  | (16,410) |  |  | (11,952)
Net liabilities |  |  |  | (16,889) |  |  | (11,746)
Capital and reserves
Called up share capital |  |  |  | 100 |  |  | 100
Profit and loss account |  |  |  | (16,989) |  |  | (11,846)
Shareholders' funds |  |  |  | (16,889) |  |  | (11,746)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
L. K Adu
Director
Approved by the board on 28 October 2025

UPHARM LIMITED
Notes to the Accounts
for the year ended 31 January 2025
1 | Accounting policies
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
| Turnover
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
2 | Employees | 2025 |  | 2024
Number | Number
| Average number of persons employed by the company | 1 |  | 1
3 | Creditors: amounts falling due within one year | 2025 |  | 2024
£ | £
| Other creditors | 585 |  | -
4 | Creditors: amounts falling due after one year | 2025 |  | 2024
£ | £
| Other creditors | 16,410 |  | 11,952
5 | Other information
| UPHARM LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
| Unit 2 Leavesden Lodge
| 1a Leavesden Road
| Prohal,
| Watford
| WD24 5FR

UPHARM LIMITED 13875631 false 2024-02-01 2025-01-31 2025-01-31 VT Final Accounts April 2025 L. K Adu No description of principal activity 13875631 2023-02-01 2024-01-31 13875631 core:WithinOneYear 2024-01-31 13875631 core:AfterOneYear 2024-01-31 13875631 core:ShareCapital 2024-01-31 13875631 core:RetainedEarningsAccumulatedLosses 2024-01-31 13875631 2024-02-01 2025-01-31 13875631 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 13875631 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 13875631 bus:Director40 2024-02-01 2025-01-31 13875631 countries:England 2024-02-01 2025-01-31 13875631 bus:FRS102 2024-02-01 2025-01-31 13875631 bus:FilletedAccounts 2024-02-01 2025-01-31 13875631 2025-01-31 13875631 core:WithinOneYear 2025-01-31 13875631 core:AfterOneYear 2025-01-31 13875631 core:ShareCapital 2025-01-31 13875631 core:RetainedEarningsAccumulatedLosses 2025-01-31 13875631 2024-01-31 iso4217:GBP xbrli:pure